Page last updated: 2024-10-30

leflunomide and Mucormycosis

leflunomide has been researched along with Mucormycosis in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Mucormycosis: Infection in humans and animals caused by any fungus in the order MUCORALES (e.g., RHIZOPUS; MUCOR; CUNNINGHAMELLA; APOPHYSOMYCES; ABSIDIA; SAKSENAEA and RHIZOMUCOR) There are many clinical types associated with infection including central nervous system, lung, gastrointestinal tract, skin, orbit and paranasal sinuses. In humans, it usually occurs as an OPPORTUNISTIC INFECTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Klatt, JC1
Gröbe, A1
Schmelzle, R1
Atac, A1
Heiland, M1
Blessmann, M1
Pohlenz, P1

Other Studies

1 other study available for leflunomide and Mucormycosis

ArticleYear
A series of complications after third molar osteotomy in a pancytopenia patient and spontaneous healing after bone marrow transplantation.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2011, Volume: 69, Issue:10

    Topics: Adult; Anti-Bacterial Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Bone Marrow Transplantati

2011